Why biosimilars matter: insights from a health care leader
In this special sponsored episode, we focus on biosimilar medications and how they can benefit patients. I'm joined by Tim de Gavre, the VP and chief commercial officer at Sandoz, a member of the Sandoz U.S. Executive Committee, and a graduate of The Wharton School and Princeton University. In this…